Abstract
Methotrexate has historically thought to be able to cause pulmonary fibrosis and this potential side effect is listed in major textbooks, patient information leaflets and national guidelines. This belief is based on a very small number of previously published isolated case reports; however, when these reports are scrutinised, such cases of pulmonary fibrosis arising many years after the introduction of methotrexate could represent other interstitial lung diseases unrelated to methotrexate.2,3 Once dogma is established, it can be difficult to undo. This article is protected by copyright. All rights reserved.
Original language | English |
---|---|
Pages (from-to) | 591-592 |
Number of pages | 2 |
Journal | Clinical and Experimental Dermatology |
Volume | 44 |
Issue number | 5 |
Early online date | 28 Mar 2019 |
DOIs | |
Publication status | Published - Jul 2019 |
ASJC Scopus subject areas
- Dermatology